9-136502974-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017617.5(NOTCH1):​c.5167+208C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0341 in 734,444 control chromosomes in the GnomAD database, including 570 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 91 hom., cov: 33)
Exomes 𝑓: 0.036 ( 479 hom. )

Consequence

NOTCH1
NM_017617.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -0.173

Publications

5 publications found
Variant links:
Genes affected
NOTCH1 (HGNC:7881): (notch receptor 1) This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]
NOTCH1 Gene-Disease associations (from GenCC):
  • Adams-Oliver syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • Adams-Oliver syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • aortic valve disease 1
    Inheritance: AD Classification: STRONG Submitted by: G2P, PanelApp Australia
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leukodystrophy
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial bicuspid aortic valve
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 9-136502974-G-A is Benign according to our data. Variant chr9-136502974-G-A is described in ClinVar as Benign. ClinVar VariationId is 133357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0285 (4345/152230) while in subpopulation NFE AF = 0.0443 (3014/68008). AF 95% confidence interval is 0.043. There are 91 homozygotes in GnomAd4. There are 2117 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 4345 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH1NM_017617.5 linkc.5167+208C>T intron_variant Intron 27 of 33 ENST00000651671.1 NP_060087.3 P46531
NOTCH1XM_011518717.3 linkc.4444+208C>T intron_variant Intron 24 of 30 XP_011517019.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH1ENST00000651671.1 linkc.5167+208C>T intron_variant Intron 27 of 33 NM_017617.5 ENSP00000498587.1 P46531

Frequencies

GnomAD3 genomes
AF:
0.0286
AC:
4349
AN:
152112
Hom.:
91
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00753
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0211
Gnomad ASJ
AF:
0.0251
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00849
Gnomad FIN
AF:
0.0483
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0444
Gnomad OTH
AF:
0.0244
GnomAD2 exomes
AF:
0.0275
AC:
3704
AN:
134734
AF XY:
0.0274
show subpopulations
Gnomad AFR exome
AF:
0.00617
Gnomad AMR exome
AF:
0.0161
Gnomad ASJ exome
AF:
0.0282
Gnomad EAS exome
AF:
0.000285
Gnomad FIN exome
AF:
0.0468
Gnomad NFE exome
AF:
0.0465
Gnomad OTH exome
AF:
0.0275
GnomAD4 exome
AF:
0.0356
AC:
20725
AN:
582214
Hom.:
479
Cov.:
6
AF XY:
0.0344
AC XY:
10773
AN XY:
313150
show subpopulations
African (AFR)
AF:
0.00787
AC:
129
AN:
16396
American (AMR)
AF:
0.0167
AC:
578
AN:
34664
Ashkenazi Jewish (ASJ)
AF:
0.0292
AC:
589
AN:
20160
East Asian (EAS)
AF:
0.000125
AC:
4
AN:
32120
South Asian (SAS)
AF:
0.00920
AC:
575
AN:
62516
European-Finnish (FIN)
AF:
0.0510
AC:
1689
AN:
33116
Middle Eastern (MID)
AF:
0.00457
AC:
19
AN:
4158
European-Non Finnish (NFE)
AF:
0.0462
AC:
16068
AN:
347470
Other (OTH)
AF:
0.0340
AC:
1074
AN:
31614
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1224
2448
3672
4896
6120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0285
AC:
4345
AN:
152230
Hom.:
91
Cov.:
33
AF XY:
0.0284
AC XY:
2117
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.00751
AC:
312
AN:
41540
American (AMR)
AF:
0.0211
AC:
322
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0251
AC:
87
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00850
AC:
41
AN:
4824
European-Finnish (FIN)
AF:
0.0483
AC:
512
AN:
10608
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0443
AC:
3014
AN:
68008
Other (OTH)
AF:
0.0237
AC:
50
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
220
439
659
878
1098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0269
Hom.:
31
Bravo
AF:
0.0253
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.67
DANN
Benign
0.59
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11574905; hg19: chr9-139397426; COSMIC: COSV53026047; API